Key facts
- This page summarizes Glendon E. French III's Form 4 filing for Pulmonx Corp (LUNG).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2026, 16:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
No transaction description listed
Additional SEC filing notes
Footnote F1
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
Footnote F2
Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
Footnote F3
Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of June 2, 2025.
Footnote F4
The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.